Tolentino, Silverio E.
HRN: 04-00-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
CIPROFLOXACIN 500MG (TAB)
11/16/2023
11/22/2023
PO
500mg/tab
Q12
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes